- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 207.97M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $12.05B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $12.03B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $110M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $109M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.05B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.16B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.14B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.27B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $28.12B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $28.21B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.79B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.75B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $32.4B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $32.59B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $866M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $726M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 216M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $264M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $80M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.73 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.73 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $500M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$158M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $485M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.74B |